Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease

被引：4

作者：

Sugai, Fuminobu ^{[1
]}

Kokunai, Yosuke ^{[1
]}

Yamamoto, Yoichi ^{[1
]}

Hashida, Goichi ^{[2
]}

Shimazu, Kengo ^{[2
]}

Mihara, Masahito ^{[1
]}

Inoue, Satoru ^{[2
]}

Sakoda, Saburo ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan

[2] Osaka Univ Hosp, Rehabil Unit, Osaka 553, Japan

来源：

JOURNAL OF NEUROLOGY | 2010年 / 257卷 / 03期

关键词：

Pompe disease; Late onset; Muscle volume analyzer; Bioelectric impedance; Handheld dynamometer;

D O I：

10.1007/s00415-009-5367-0

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The muscle volume analyzer (MVA) can predict limb muscle weight based on bioelectric impedance analysis, whereas the conventional handheld dynamometer (HHD) measures muscle strength. In this study, a 26-year-old female on invasive ventilation due to late-onset Pompe disease was treated with enzyme replacement therapy (ERT) for 12 months. MVA measurements demonstrated time-dependent improvement from the baseline compared to HHD measurements, showing remarkably fluctuating muscle strength. Thus, the MVA can be used as an alternative, particularly for patients suffering from severe limb muscle weakness.

引用

页码：461 / 463

页数：3

共 50 条

[21] Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Hundsberger, Thomas
Rohrbach, Marianne
Kern, Lukas
Roesler, Kai M.
JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2279 - 2285
[22] Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Thomas Hundsberger
Marianne Rohrbach
Lukas Kern
Kai M. Rösler
Journal of Neurology, 2013, 260 : 2279 - 2285
[23] Gastrointestinal symptoms in late-onset Pompe disease: Early response to enzyme replacement therapy
Pardo, Julio
Garcia-Sobrino, Tania
Lopez-Ferreiro, Ana
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 353 (1-2) : 181 - 182
[24] Enzyme replacement therapy treatment patterns and patient outcomes in late-onset Pompe disease
Kurashige, Ian
Baek, Aiden
Pichardo, Angel
Myrick, Shane
Horowicz-Mehler, Nathalie
Curran, Marla
Savola, Juha-Matti
Gabriel, Kristin
Tavakkoli, Fatameh
MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S60 - S61
[25] Enzyme replacement therapy reduces glycogen in skeletal muscle biopsies of late-onset Pompe patients
Thurberg, Beth
MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S90 - S90
[26] A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
Dornelles, Alicia Dorneles
Junges, Ana Paula Pedroso
Pereira, Tiago Veiga
Krug, Barbara Correa
Goncalves, Candice Beatriz Treter
Llerena Jr, Juan Clinton
Kishnani, Priya Sunil
de Oliveira Jr, Haliton Alves
Schwartz, Ida Vanessa Doederlein
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
[27] Late-onset Pompe disease after 4 years of enzyme replacement therapy: An autopsy case
Furusawa, Yoshihiko
Mitsuhashi, Satomi
Mori-Yoshimura, Madoka
Shimada, Yohta
Yamamoto, Toshiyuki
Shibuya, Makoto
Shimizu, Jun
Ohashi, Toya
Saito, Yuko
Nishino, Ichizo
Oya, Yasushi
Murata, Miho
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2014, 2 (01): : 7 - 9
[28] ENZYME REPLACEMENT THERAPY INDUCES T-CELL RESPONSES IN LATE-ONSET POMPE DISEASE
Banati, Miklos
Hosszu, Zsolt
Trauninger, Anita
Szereday, Laszlo
Illes, Zsolt
MUSCLE & NERVE, 2011, 44 (05) : 720 - 726
[29] Enzyme replacement therapy in late-onset Pompe disease patients: an experience of a Portuguese universitary hospital
Vicente, B.
Oliveira Santos, M.
Godinho Oliveira, F.
Moreira, S.
Conceicao, I.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 738 - 738
[30] Enzyme replacement therapy with alglucosidase alfa in a late-onset Pompe disease patient during pregnancy
Santos, Miguel Oliveira
Evangelista, Teresinha
Conceicao, Isabel
NEUROMUSCULAR DISORDERS, 2018, 28 (11) : 965 - 968

← 1 2 3 4 5 →